Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Effects of Dexmedetomidine on Cardiac Troponin I and Glycogen Phosphorylase Isoenzyme BB in Patients Undergoing Off-pump Coronary Artery Bypass Grafting
NCT03163693Unknown
- Sponsor
- General Hospital of Ningxia Medical University
- Start
- Feb 2016
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of dexmedetomidine in coronary artery disease (CAD) (2 arms), sponsored by General Hospital of Ningxia Medical University. Primary endpoints: Cardiac Troponin I and Glycogen Phosphorylase Isoenzyme BB. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT03163693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03163693.